Aging Communications, 2024
Multimodal comparison of plasma proteins associated with blood-brain barrier impairment in Alzheimer’s disease

Giunti E., Collu R., Reisman J. et al.

Blood Advances, 2024
Longitudinal plasma proteomics in CAR T–cell therapy patients implicates neutrophils and NETosis in the genesis of CRS

Flora C., Olesnavich M., Zuo Y. et al.

Cells, 2024
The Role of CCL24 in Primary Sclerosing Cholangitis: Bridging Patient Serum Proteomics to Preclinical Data

Greenman R., Snir T., Katav A. et al.

Reproductive Sciences, 2024
Novel Associations Between Mid-Pregnancy Cardiovascular Biomarkers and Preeclampsia: An Explorative Nested Case-Control Study

Callbo P., Junus K., Gabrysch K. et al.

Journal of Cystic Fibrosis, 2024
Key inflammatory markers in bronchoalveolar lavage predict bronchiectasis progression in young children with CF

Horati H., Margaroli C., Chandler J. et al.

Journal of Investigative Dermatology, 2024
IL-26 Potentiates Type 2 Skin Inflammation in the Presence of IL-1β

Bier K., Senajova Z., Henrion F. et al.

Clinica Chimica Acta, 2024
Targeted proteomics and metabolomics for biomarker discovery in abdominal aortic aneurysm and post-EVAR sac volume

Vanmaele A., Bouwens E., Hoeks S. et al.

iScience, 2024
Proteome-wide Mendelian randomization identifies causal plasma proteins in lung cancer

Li H., Du S., Dai J. et al.

PLOS ONE, 2024
Feasibility demonstration of a device for vitreous liquid biopsy incidental to intravitreal injection

Tumlinson A., Calara J., Azar D. et al.

Journal of Lipid Research, 2024
Changes in soluble LDL receptor and lipoprotein fractions in response to diet in the DIETFITS weight loss study

Krauss R., Fisher L., King S. et al.

Immunity, Inflammation and Disease, 2024
The functional role of CST1 and CCL26 in asthma development

Hoyer A., Chakraborty S., Lilienthal I. et al.

Translational Psychiatry, 2024
Inflammatory biotype of ADHD is linked to chronic stress: a data-driven analysis of the inflammatory proteome

Schnorr I., Siegl A., Luckhardt S. et al.

Cell Reports Medicine, 2024
Inhibition of CSF-1R and IL-6R prevents conversion of cDC2s into immune incompetent tumor-induced DC3s boosting DC-driven therapy potential

Becker A., Decker A., Flórez-Grau G. et al.

Annals of Clinical and Translational Neurology, 2024
Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis

Jalaleddini K., Jakimovski D., Keshavan A. et al.

GeroScience, 2024
Association of postoperative delirium with serum and cerebrospinal fluid proteomic profiles: a prospective cohort study in older hip fracture patients

Lozano-Vicario L., Muñoz-Vázquez ?., Ramírez-Vélez R. et al.

Journal of Clinical Immunology, 2024
Autoantibody-Mediated Depletion of IL-1RA in Still’s Disease and Potential Impact of IL-1 Targeting Therapies

Hoffmann M., Cavalli G., Fadle N. et al.

Cell Reports Medicine, 2024
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids

Sasidharan K., Caddeo A., Jamialahmadi O. et al.

Nature Communications, 2024
Large scale plasma proteomics identifies novel proteins and protein networks associated with heart failure development

Shah A., Myhre P., Arthur V. et al.

BMC Immunology, 2024
Whole blood stimulation provides preliminary evidence of altered immune function following SRC

Di Battista A., Rhind S., Shiu M. et al.

Nature Immunology, 2024
Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2

Yin K., Peluso M., Luo X. et al.